Patent ID: 11945824
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 5:
6. The compound of claim 1, represented by one of Formulae (XIe)˜(XIg), or Formulae (XIj)˜(XIk), or a pharmaceutically acceptable salt thereof:, , wherein each R11 is independently optionally substituted —C1-C6 alkyl, optionally substituted C1-C6 alkoxyl, optionally substituted —C3-C6 cycloalkyl, halo, —CN, or -NRaRb R12 is hydrogen, optionally substituted —C1-C6 alkyl, optionally substituted C1-C6 alkoxyl, optionally substituted —C3-C6 cycloalkyl, halo, —CN, or —NRaRb; each Ra and Rb is independently selected from hydrogen, optionally substituted —C1-C6 alkyl, and optionally substituted —C3-C6 cycloalkyl; alternatively, Ra and Rb are taken together with the nitrogen atom to which they attached to form an optionally substituted heterocyclic ring; R13 is hydrogen, optionally substituted —C1-C6 alkyl, optionally substituted —C3-C6 cycloalkyl; each p′ is 0, or 1; each m is 0, 1, 2, 3, 4 or 5; and Y, G, R3, R4, are as defined in claim 1.